Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50144342 (3-((1R,3S)-3-Amino-cyclopentyl)-2-[1-(3,3-dimethyl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50089691 (CHEMBL3577425) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Institute for Infection Research Curated by ChEMBL | Assay Description Inhibition of CBP (unknown origin) | J Med Chem 58: 4839-44 (2015) Article DOI: 10.1021/jm501840b BindingDB Entry DOI: 10.7270/Q24B3314 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50144336 (3-(6-Amino-5-methyl-pyridin-3-yl)-2-[1-(3-methyl-b...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50144333 (3-(6-Amino-5-methyl-pyridin-3-yl)-2-[1-(4-methyl-p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120796 (US8710232, 33) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50135934 (3-(6-Amino-pyridin-3-yl)-2-[1-(3-methyl-butyl)-1H-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50144337 (3-(6-Amino-pyridin-3-yl)-2-[1-(4-methyl-pentyl)-1H...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120790 (US8710232, 17) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120788 (US8710232, 15) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120787 (US8710232, 13) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120786 (US8710232, 12) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120782 (US8710232, 7) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50144316 (3-(6-Amino-5-methyl-pyridin-3-yl)-2-(1H-imidazol-4...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120791 (US8710232, 18) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120785 (US8710232, 10) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120781 (US8710232, 1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120789 (US8710232, 16) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120797 (US8710232, 37) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50135933 (3-(6-Amino-pyridin-3-yl)-2-(1H-imidazol-4-yl)-prop...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50144325 (3-((1R,3S)-3-Amino-cyclopentyl)-2-(1-ethyl-1H-imid...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50144317 (6-Amino-2-[1-(3-methyl-butyl)-1H-imidazol-4-yl]-he...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50089685 (CHEMBL3577333) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Institute for Infection Research Curated by ChEMBL | Assay Description Inhibition of CBP (unknown origin) | J Med Chem 58: 4839-44 (2015) Article DOI: 10.1021/jm501840b BindingDB Entry DOI: 10.7270/Q24B3314 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50233004 (2-(3-carbamimidamidopropylidene)butanedioic acid |...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a | n/a |
Griffith University Curated by ChEMBL | Assay Description Inhibition of carboxypeptidase B | Bioorg Med Chem Lett 18: 1495-7 (2008) Article DOI: 10.1016/j.bmcl.2007.12.060 BindingDB Entry DOI: 10.7270/Q2GB23T5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120784 (US8710232, 9) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 439 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50144320 (6-Amino-2-(1H-imidazol-4-yl)-5,5-dimethyl-hexanoic...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120795 (US8710232, 31) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 870 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120793 (US8710232, 27) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120783 (US8710232, 8) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120794 (US8710232, 28) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.44E+3 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50144322 (6-Amino-2-(1H-imidazol-4-yl)-5-methyl-hexanoic aci...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM50144334 (6-Amino-2-(1H-imidazol-4-yl)-hexanoic acid | CHEMB...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 3.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human carboxypeptidase B (CPB) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Carboxypeptidase B (Homo sapiens (Human)) | BDBM120792 (US8710232, 25) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.05E+4 | n/a | n/a | n/a | n/a | 7.4 | 25 |
Sanofi-Aventis Deutschland GmbH US Patent | Assay Description The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ... | US Patent US8710232 (2014) BindingDB Entry DOI: 10.7270/Q2KW5DQ4 | |||||||||||
More data for this Ligand-Target Pair |